Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitively Normal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Not applicableLooking for participantsNCT07516119
What this trial is testing

Predicting Pre-dementia

Who this might be right for
Mild Cognitive Impairment (MCI)Alzheimer Dementia (AD)Alzheimer Disease (AD)+1 more
Prevention Research Consortium Corp. 100
Not applicableActive Not RecruitingNCT06721390
What this trial is testing

Music Improvisation Training on Cognitive Function in Older Adults

Who this might be right for
AgingCognitive AgingCognitive Impairment+3 more
University of California, San Francisco 238
Large-scale testing (Phase 3)Looking for participantsNCT07115238
What this trial is testing

Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD

Who this might be right for
Alzheimer DiseaseNeurofibrillary Tangle
Sinotau Pharmaceutical Group 354
Not applicableStudy completedNCT01222351
What this trial is testing

Measuring Brain Amyloid Plaque Load in Older Adults Using BAY 94-9172

Who this might be right for
Late Onset Alzheimer Disease
New York State Psychiatric Institute 161
Very early researchStudy completedNCT01729598
What this trial is testing

Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study

Who this might be right for
Alzheimer's Disease
Gregory Jicha, 323-5550 14
Large-scale testing (Phase 3)Study completedNCT02913664
What this trial is testing

Risk Reduction for Alzheimer's Disease

Who this might be right for
Cognitively Normal Older AdultsHypertensionSubjective Cognitive Decline+1 more
University of Texas Southwestern Medical Center 513
Testing effectiveness (Phase 2)Active Not RecruitingNCT05331144
What this trial is testing

Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)

Who this might be right for
Cognitively Normal Older AdultsHypertensionSubjective Cognitive Decline+1 more
Rong Zhang 180
Early research (Phase 1)Study completedNCT00757939
What this trial is testing

Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 40
Testing effectiveness (Phase 2)Study completedNCT00814346
What this trial is testing

Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

Who this might be right for
Alzheimer's DiseaseCognitive Impairment
Ipsen 49
Testing effectiveness (Phase 2)Looking for participantsNCT07477431
What this trial is testing

Levetiracetam for Persons at Risk for Alzheimer's Disease

Who this might be right for
Hippocampal HyperactivationProdromal Alzheimer Disease
Sunnybrook Health Sciences Centre 40
Testing effectiveness (Phase 2)Study completedNCT02656498
What this trial is testing

[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Jae Seung Kim 135
Post-approval studies (Phase 4)Study completedNCT01142336
What this trial is testing

Effects of Simvastatin on Biomarkers

Who this might be right for
Alzheimer's Disease
University of Washington 49
Not applicableStudy completedNCT02472899
What this trial is testing

Biomarker Study for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Beersheva Mental Health Center 115
Not applicableStudy completedNCT05604365
What this trial is testing

FearLess in Cognitively Intact Patients With Glioma

Who this might be right for
GliomaFear of Cancer
Virginia Commonwealth University 22
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Not applicableStudy completedNCT05980286
What this trial is testing

Impact of Music Improvisation Training on Cognitive Function in Older Adults

Who this might be right for
AgingCognitive AgingCognitive Impairment+3 more
University of California, San Francisco 53
Testing effectiveness (Phase 2)Study completedNCT03903211
What this trial is testing

Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease

Who this might be right for
Cognitively NormalMild Cognitive ImpairmentAlzheimer Disease
Jae Seung Kim 84
Testing effectiveness (Phase 2)Study completedNCT00855868
What this trial is testing

Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 28